1. Liu WL, Gao M, Tzen KY, Tsai CL, Hsu FM, Cheng AL, Cheng JC*. Targeting
phosphatidylinositide3-kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular
carcinoma. Oncotarget 5:3662-3672, 2014 (SCI)
2. Cheng JC, Graber MS, Hsu FM, Tsai CL, Castaneda L, Lee JM, Chang DT, Koong AC*.
High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1
before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal
squamous cell carcinoma receiving combined modality therapy. Annals of Surgical Oncology
21:2361-2368, 2014 (SCI)
3. Lin ZZ, Chou CH, Cheng AL, Liu WL*, Cheng JC*. Radiosensitization by combining an Aurora
kinase inhibitor with radiotherapy in hepatocellular carcinoma through cell cycle interruption.
International Journal of Cancer 135:492-501, 2014 (SCI)
4. Cheng JC, Bazan JG, Wu JK, Koong AC, Chang DT. Lumbosacral spine and marrow cavity
modeling of acute hematologic toxicity in patients treated with intensity modulated radiation
therapy for squamous cell carcinoma of the anal canal. Practical Radiation Oncology 4:198-206,
2014
5. Tsai YC, Yeh CH, Tzen KY, Ho PY, Tuan TF, Pu YS, Cheng AL, Cheng JC*. Targeting
EGFR/HER2 signaling pathway by a dual receptor tyrosine kinase inhibitor afatinib for
radiosensitization in murine bladder carcinoma. Eur J Cancer 2013 (SCI) (in press)
6. Tsai CL, Koong AC, Hsu FM, Graber M, Chen IS, Cheng JC*. Biomarker studies on radiotherapy
to hepatocellular carcinoma. Oncology 2013 (SCI) (in press)
7. Tsai CL, Chung HT, Chu W, Cheng JC*. Radiation therapy for primary and metastatic tumors of
the liver. Journal of Radiation Oncology 1:227-237, 2012
8. Chou CH, Teng CM, Tzen KY, Chang YC, Chen JH, Cheng JC*. MMP-9 from sublethally
irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasis.
Oncogene 31:458-468, 2012 (SCI)
9. Lu YS, Chou CH, Tzen KY, Gao M, Cheng AL, Kulp SK, Cheng JC*. Radiosensitizing effect of a
phenylbutyrate-derived histone deacetylase inhibitor in hepatocellular carcinoma. International
Journal of Radiation Oncology, Biology, Physics 83:e181-e189, 2012 (SCI)
10. Wu JK, Wu CJ, Cheng JC*. Programmable segmented volumetric modulated arc therapy for
respiratory coordination in pancreatic cancer. Radiotherapy and Oncology 104:386-389, 2012
(SCI)
11. Chao HL, Chen WL, Hu CC, Wu JK, Wu CJ, Cheng JC*. Phase-specific cone beam computed
tomography reduces reconstructed volume loss of moving phantom. Strahlentherapie und Onkologie
188;77-83, 2012 (SCI)
12. Hsu FM, Lee JM, Huang PM, Lin CC, Hsu CH, Tsai YC, Lee YC, Cheng JC*. A retrospective
analysis of outcome difference in preoperative concurrent chemoradiation with or without elective
nodal irradiation for esophageal squamous cell carcinoma. International Journal of Radiation
Oncology, Biology, Physics 81:e593-e599, 2011 (SCI)
13. Lo TC, Hsu FM, Chang CA, Cheng JC*. Branched -(1,4) Glucans from Lentinula edodes (L10) in
combination with radiation enhances cytotoxic effect on human lung adenocarcinoma through the
Toll-like receptor 4 mediated induction of THP-1 differentiation/activation. J Agric Food Chem
59:11997-12005, 2011 (SCI)
14. Hu CC, Huang WT, Tsai CL, Wu JK, Chao HL, Huang GM, Wang CW, Wu CJ, Cheng JC*.
Practically acquired and modified cone-beam computed tomography images for accurate dose
calculation in head and neck cancer. Strahlentherapie und Onkologie 187:633-644, 2011 (SCI)
15. Tsai CL, Wu JK, Chao HL, Tsai YC, Cheng JC*. Treatment and dosimetric advantages between
VMAT, IMRT, and helical tomotherapy in prostate cancer. Med Dosim 36:264-271, 2011 (SCI)
16. Chou CH, Chen SU, Cheng JC*. Radiation-Induced IL-6 Expression through MAPK/p38/NF-κB
Signaling Pathway and the Resultant Anti-Apoptotic Effect on Endothelial Cells through Mcl-1
Expression with sIL6-Rα. International Journal of Radiation Oncology, Biology, Physics
75:1553-1561, 2009 (SCI)
17. Chou CH, Chen PJ, Jeng YM, Cheng AL, Huang LR, Cheng JC*. Synergistic effect of radiation
and interleukin-6 on hepatitis B virus reactivation in liver through STAT3 signaling pathway.
International Journal of Radiation Oncology, Biology, Physics 75:1545-1552, 2009 (SCI)
18. Tsai CL, Wu JK, Wang CW, Hsu FM, Lai MK, Cheng JC*. Using cone-beam computed
tomography to evaluate the impact of bladder filling status on target position in prostate
radiotherapy. Strahlentherapie und Onkologie 185:588-595, 2009 (SCI)
19. Jeng SC, Tsai CL, Chan WT, Tung CJ, Wu JK, Cheng JC*. Mathematical estimation and in vivo
dose measurement for cone-beam computed tomography on prostate cancer patients. Radiother
Oncol 92:57-61, 2009 (SCI)
20. Lee KW, Wu JK, Jeng SC, Hsueh YW, Cheng JC*. Skin dose impact from vacuum immobilization
device and carbon fiber couch in intensity modulated radiation therapy for prostate cancer. Med
Dosim 34:228-232, 2009 (SCI)
21. Kuo WC, Chan CH, Chou CH, Cheng JC*. Swept source optical coherence tomography for
radiation-enhanced hepatocellular carcinoma cell invasion imaging. Phys Med Biol 54:4289-4297,
2009 (SCI)
22. Hsu FM, Lee YC, Lee JM, Hsu CH, Lin CC, Tsai YC, Wu JK, Cheng JC*. Association of clinical
and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients
receiving intensity modulated radiation therapy and concurrent chemotherapy followed by thoracic
esophagectomy. Ann Surg Oncol 16:1669-1677, 2009 (SCI)
23. Wang YJ, Hsu FM, Chen YH, Tsai CL, Chen WY, Cheng JC, Kuo SH. Radiotherapy for
intracranial germinoma: treatment modalities and clinical outcome. Therapeut Radiol Oncol 21:
111-119, 2014
24. Tu CY, Huang WT, Huang GM, Lu SH, Cheng JC, Wang CW, Wen SY. Gafchromic EBT2 film:
Dosimetry verification and characteristic investigation. Taiwanese Journal of Applied Radiation
and Isotopes 8:289-297, 2012.
25. Xu YJ, Cheng JC, Lee JM, Chen CC. Management of Malnutrition in Esophageal Cancer Patients.
J Cancer Res Prac 1:3-13, 2014.
26. Chow PM, Chiang IN, Cheng JC, Chiang BJ, Pu YS, Huang CY. Pretreatment prostate specific
antigen (PSA) and 2-year PSA dynamics: Early predictors of prostate cancer prognosis with
external radiation therapy. Urology Science 24:120-123, 2013.
27. Hong TS, Bosch WR, Krishnan S, Kim TK, Mamon HJ, Shyn P, Ben-Josef E, Seong J, Haddock
MG, Cheng JC, Feng MU, Stephans KL, Roberge D, Crane C, Dawson LA. Interobserver
variability in target definition for hepatocellular carcinoma with and without portal vein thrombus:
radiation therapy oncology group consensus guidelines. Int J Radiat Oncol Biol Phys 89:804-813,
2014. (SCI)
28. Chang DT, Brunner T, Cheng JC, Liauw S, Meyer J, Wo J. Oncology scan-novel treatment
strategies for gastrointestinal cancers. Int J Radiat Oncol Biol Phys 89:699-703, 2014. (SCI)
29. Chen YH, Pan SL, Wang JC, Kuo SH, Cheng JC, Teng CM. Radiation-induced VEGF-C
expression and endothelial cell proliferation in lung cancer. Strahlenther Onkol 188:878-886, 2014
(SCI) (in press)
30. Liang HK, Wang CW, Tseng HM, Huang CY, Lan KH, Chen YH, You SL, Cheng JC, Cheng AL,
Kuo SH. Preoperative prognostic neurologic index for glioblastoma patients receiving tumor
resection. Ann Surg Oncol 2014 (SCI) (in press)
31. Chen JL, Huang CY, Huang YS, Chen RJ, Wang CW, Chen YH, Cheng JC, Cheng AL, Kuo SH.
Differential clinical characteristics, treatment response and prognosis of locally advanced
adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with
definitive radiotherapy. Acta Obstet Gynecol Scand 93:661-668, 2014. (SCI)
32. Liang JT, Cheng JC, Huang KC, Lai HS, Sun CT. Comparison of tumor recurrence between
laparoscopic total mesorectal excision with sphincter preservation and laparoscopic
abdominoperineal resection for low rectal cancer. Surgical Endoscopy 27:3452-3464, 2013 (SCI)
33. Shao YY, Liang PC, Wu YM, Huang CC, Huang KW, Cheng JC, Hsu CH, Hsu C, Cheng AL, Lin
ZZ. A pilot study of hepatic arterial infusion of chemotherapy for patients with advanced
hepatocellular carcinoma who have failed anti-angiogenic therapy. Liver International
33:1413-1419, 2013 (SCI)
34. Chen JL, Cheng JC, Kuo SH, Chan HM, Huang YS, Chen YH. Prone breast forward
intensity-modulated radiotherapy for Asian women with early left breast cancer: factors for cardiac
sparing and clinical outcomes. Journal of Radiation Research 54:899-908, 2013 (SCI)
35. Lai SF, Wang CW, Chen YH, Lan KH, Cheng JC, Cheng AL, Kuo SH. Medulloblastoma in adults.
Treatment outcome, relapse patterns, and prognostic factors. Strahlenther Onkol 188:878-886, 2012
(SCI)
36. Chen JL, Cheng JC, Kuo SH, Chen CA, Lin MC, Huang CY. Outcome analysis of cervical
adenosquamous carcinoma compared with adenocarcinoma. Acta Obstet Gynecol Scand
91:1158-1166, 2012 (SCI)
37. Lu SH, Cheng JC, Kuo SH, Lee JJ, Chen LH, Wu JK, Chen YH, Chen WY, Wen SY, Chong FC,
Wu CJ, Wang CW. Volumetric modulated arc therapy for nasopharyngeal carcinoma: A dosimetirc
comparison with TomoTherapy and step-and-shoot IMRT. Radiother Oncol 104:324-330, 2012
(SCI)
38. Chen WY, Kuo SH, Chen YH, Lu SH, Tsai CL, Cheng JC, Hong RL, Chen YF, Hsu CJ, Lin KN,
Ko JY, Lou PJ, Wang CP, Chong FC, Wang CW. Post-operative intensity-modulated radiotherapy
for squamous cell carcinoma of the external auditory canal and middle ear: Treatment outcomes,
margin misses, and perspective on target delineation. Int J Radiat Oncol Biol Phys 82:1485-1493,
2012 (SCI)
39. Liang HK, Huang CY, Wang CW, Chen YH, Kuo SH, Cheng JC. Clinical characteristics, imaging
fimdings, and treatment modalities associate with outcome of patients with glioblastoma
multiforme. Therapeutic Radiology and Oncology 19:93-104, 2012
40. Hsu CY, Cheng JC, Kuo SH, Chen YH, Tsai CL, Lan KH, Chen WY, Wang CW. Treatment
outcomes for synchronous or metachronous hypopharyngeal/laryngeal/oropharyngeal cancer and
esophageal cancer. Therapeutic Radiology and Oncology 19:119-129, 2012
41. Lee JM, Yang SY, Yang PW, Shun CT, Wu MT, Hsu CH, Lin CC, Cheng JC, Wang YH, Chuang
TH, Chen JS, Hsu HH, Huang PM, Kuo SW, Lee YC. Polymorphism in Epidermal Growth Factor
Receptor Intron 1 Predicts Prognosis of Patients with Esophageal Cancer after Chemoradiation and
Surgery. Annals of Surgical Oncology 18:2066-2073, 2011
42. Chen WY, Cheng JC, Lee YC, Hsu FM. Retrospective analysis of outcomes for patients with
invasive thymoma receiving surgery with or without adjuvant radiotherapy. Therapeutic Radiology
and Oncology 18:17-26, 2011
43. Lin WJ, Huang AJ, Hu CC, Huang GM, Wu JK, Cheng JC. The use of computed tomography for
evaluation of the dose calculation effect in the presence of metallic dental prostheses on head and
neck radiotherapy. Taiwan Journal of Applied Radiation and Isotopes 7:101-109, 2011
44. Huang AJ, Lin WJ, Hu CC, Huang GM, Wu JK, Cheng JC. The dosimetric impact from metal
artifact of hip prostheses on CT images. Taiwan Journal of Applied Radiation and Isotopes
7:129-136, 2011
45. Lin YC, Cheng WL, Tseng HM, Cheng JC, Xiao FR, Chen CM, Chong FC, Wang CW.
Investigation of relationship between intrafractional displacement and treatment time in intracranial
radiosurgery. Chinese Journal of Radiologic Technology 34:161-168, 2010
46. Lan KH, Chen YH, Wu LK, Hsu FM, Wang CW, Cheng CH. The prognostic factors and short-term
outcome of intensity-modulated radiotherapy for patients with prostatic adenocarcinoma. Therapeut
Radiol Oncol 17:9-18, 2010
47. Huang KM, Cheng JC, Huang WT. Parameters calibration of electron beam radiotherapy for single
lesion kaposi's sarcoma. Journal of Gamma 40:46-51, 2009
48. Lin CC, Hsu CH, Cheng JC, Huang CY, Tsai YC, Hsu FM, Huang KH, Cheng AL, Pu YH*.
Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation
for muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 75:442-448, 2009 (SCI)